Security (S&B/CBRNE) Magazine

SPR 2016

Security & Border Protection and CST & CBRNE Source Book, published jointly, concentrate on WMD response, NGB training, counterterrorism, and border security

Issue link:

Contents of this Issue


Page 16 of 35 S&BP and CST & CBRNE | Spring 2016 | 15 Director's Corner requirements, and formalizing training. The Unmanned Ground Vehicle Sensor Suite Integration effort is one effort to this end. The sensor suite is a dedicated system of nuclear and chemical detection and warning equipment and biological sampling gear. Units receiving equipment and support include the National Guard WMD Civil Support Teams, the National Guard Chemical, Biological, Radiological, Nuclear, and High Yield Explosives Enhanced Response Force Packages, the U.S. Marine Corps Chemical Biological Incident Response Force, and the U.S. Army's 20th CBRNE Command. CST & CBRNE: From an industry partnering perspective, how is JPEO-CBD working to maximize cooperation? Mr. Bryce: Fundamentally, we are being responsive to the challenges industry faces. The medical countermeasures (MCM) development business is a good example. In an effort to facilitate opportunities, we are working with industry experts to develop a suite of incentives, potentially including the FDA priority review voucher program (i.e. FDA taking action on an application within 6 months compared to 10 months under standard review) to address risk in candidate MCM development, as well as pursuing the previously mentioned OTA initiative. Our intent with the new Medical Countermeasures Advanced Development and Manufacturing (MCM ADM) facility in Florida is to promote competition and incentivize businesses to compete by making it more likely our small innovator biopharmaceutical performers that lack the FDA regulatory and production experience can and will succeed at fulfilling DoD requirements. This broadens the community of potentially capable and potentially interested performers. Ensuring these performers succeed for DoD is fundamental to the purpose of the MCM ADM facility. To foster their success, we keep pace and meet with our industry partners through forums such as scheduled conferences and our annual Advanced Planning Briefing to Industry event. We have made it easier for industry to do business with the JPEO through efforts such as our Omnibus Program Engineering and Technical Support Service, or OPETS; Joint Enterprise Research, Development Acquisition and Procurement or JE-RDAP; and Joint Enterprise Contracted Logistics and Services Support, or JE-CLaSS. We are committed to engaging with our industry partners. My Joint Project Managers are open to meeting with companies outside of these events and so am I. CST & CBRNE: What are some key JPEO-CBD efforts slated for 2016? Mr. Bryce: In addition to emphasis areas previously mentioned, there are other key JPEO-CBD efforts which also support specific "countering WMD activities and tasks" under the Department of Defense Strategy for Countering Weapons of Mass Destruction, in particular those which "incorporate countering WMD efforts," "cooperate with and support partners," "understand the environment, threats, and vulnerabilities," and "control, defeat, disable, and/or dispose of WMD threats." For incorporation and cooperation on medical countermeasures (MCM), for example, we will continue to participate in the Public Health Emergency Medical Countermeasures Enterprise process. Led by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, this group coordinates Federal efforts to increase national preparedness with respect to medical countermeasures. To understand the environment and threat, we will continue to develop the Joint Biological Tactical Detection System (JBTDS) and Next Generation Chemical Detector (NGCD) while improving CBRN battle management systems such as the Joint Warning and Reporting Network (JWARN). For controlling and disabling the threat, we plan to preserve and improve the kinds of capabilities which contributed so strongly to the DoD's Ebola response mission. The Critical Reagents Program (CRP), instrumental in providing the detection capability (assay) necessary to determining the presence of the disease, will now become the Defense Biological Product Assurance Office (DBPAO) with improved information management capabilities, while the Next Generation Diagnostics System (NGDS), the platform running the assay, will continue to be improved to meet unique DoD requirements in an unpredictable world.

Articles in this issue

Links on this page

Archives of this issue

view archives of Security (S&B/CBRNE) Magazine - SPR 2016